Study for the PANCE Cardiology Test. Enhance your knowledge with comprehensive flashcards and multiple-choice questions. Each question comes with hints and detailed explanations. Prepare thoroughly for your exam!

Multiple Choice

What is the treatment goal for a patient with CAD and hypertension?

In patients with coronary artery disease and hypertension, the goal of therapy is to reduce cardiovascular risk by lowering blood pressure to a level that has proven benefit and is tolerable. The commonly recommended target is a blood pressure under 130/80 mm Hg. Hitting this level helps decrease afterload and myocardial oxygen demand, which reduces the likelihood of ischemia and other events in high-risk CAD patients. It also guides clinicians to step up appropriate medications (such as ACE inhibitors or ARBs, beta blockers, calcium channel blockers, or thiazide diuretics) and lifestyle changes to achieve and maintain this level. Targets that are much tighter, like 120/80, can be difficult for many patients to maintain and may lead to adverse effects like dizziness or hypotension. Targets that are looser, such as around 140/90 or 135/85, leave more residual cardiovascular risk in individuals with established CAD. Therefore, the 130/80 target best balances risk reduction with practicality and tolerability.

In patients with coronary artery disease and hypertension, the goal of therapy is to reduce cardiovascular risk by lowering blood pressure to a level that has proven benefit and is tolerable. The commonly recommended target is a blood pressure under 130/80 mm Hg. Hitting this level helps decrease afterload and myocardial oxygen demand, which reduces the likelihood of ischemia and other events in high-risk CAD patients. It also guides clinicians to step up appropriate medications (such as ACE inhibitors or ARBs, beta blockers, calcium channel blockers, or thiazide diuretics) and lifestyle changes to achieve and maintain this level.

Targets that are much tighter, like 120/80, can be difficult for many patients to maintain and may lead to adverse effects like dizziness or hypotension. Targets that are looser, such as around 140/90 or 135/85, leave more residual cardiovascular risk in individuals with established CAD. Therefore, the 130/80 target best balances risk reduction with practicality and tolerability.